Topical immunization strategies - PubMed (original) (raw)
Review
doi: 10.1038/mi.2010.55. Epub 2010 Sep 22.
Affiliations
- PMID: 20861833
- DOI: 10.1038/mi.2010.55
Free article
Review
Topical immunization strategies
C Czerkinsky et al. Mucosal Immunol. 2010 Nov.
Free article
Abstract
Research has yielded an abundance of vaccine candidates against mucosal infections, but only few mucosal vaccines have been registered for human use. Extensive research is being carried out to identify new and safe adjuvants for mucosal immunization, novel delivery systems, including live vectors and reporter molecules for tissue- and cell-specific targeting of vaccine antigens. If these candidates are to reach those in need, several lessons from clinical and field research carried out under resource-poor settings must be considered. These lessons include the need to develop new vaccines that can be administered topically onto the skin or to the mucosa, without needles or expensive delivery devices. Such topical vaccines must be able to protect all age groups at risk, be safe and effective in immunocompromised people, and be able to contain epidemics following complex emergencies. The anatomical compartmentalization of immune responses imposes constraints on the selection of topical route(s) of vaccine administration and on strategies for measuring these responses, especially in young infants. Thus, the selection of any particular route of immunization is critical when designing and formulating vaccines against organ-specific infections.
Similar articles
- Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues.
Czerkinsky C, Holmgren J. Czerkinsky C, et al. Curr Top Microbiol Immunol. 2012;354:1-18. doi: 10.1007/82_2010_112. Curr Top Microbiol Immunol. 2012. PMID: 21053117 Review. - Novel vaccine development strategies for inducing mucosal immunity.
Fujkuyama Y, Tokuhara D, Kataoka K, Gilbert RS, McGhee JR, Yuki Y, Kiyono H, Fujihashi K. Fujkuyama Y, et al. Expert Rev Vaccines. 2012 Mar;11(3):367-79. doi: 10.1586/erv.11.196. Expert Rev Vaccines. 2012. PMID: 22380827 Free PMC article. Review. - Mucosal delivery of vaccine antigens and its advantages in pediatrics.
De Magistris MT. De Magistris MT. Adv Drug Deliv Rev. 2006 Apr 20;58(1):52-67. doi: 10.1016/j.addr.2006.01.002. Epub 2006 Mar 3. Adv Drug Deliv Rev. 2006. PMID: 16516335 Review. - Mucosal immunization: a realistic alternative.
Otczyk DC, Cripps AW. Otczyk DC, et al. Hum Vaccin. 2010 Dec;6(12):978-1006. doi: 10.4161/hv.6.12.13142. Epub 2010 Dec 1. Hum Vaccin. 2010. PMID: 21150284 Review. - Recent advances in mucosal vaccine development.
Chen H. Chen H. J Control Release. 2000 Jul 3;67(2-3):117-28. doi: 10.1016/s0168-3659(00)00199-1. J Control Release. 2000. PMID: 10825547 Review.
Cited by
- SARS-CoV-2 Spike Protein-Expressing Enterococcus for Oral Vaccination: Immunogenicity and Protection.
Suvorov A, Loginova S, Leontieva G, Gupalova T, Desheva Y, Korzhevskii D, Kramskaya T, Bormotova E, Koroleva I, Kopteva O, Kirik O, Shchukina V, Savenko S, Kutaev D, Borisevitch S. Suvorov A, et al. Vaccines (Basel). 2023 Nov 14;11(11):1714. doi: 10.3390/vaccines11111714. Vaccines (Basel). 2023. PMID: 38006046 Free PMC article. - Putative novel outer membrane antigens multi-epitope DNA vaccine candidates identified by Immunoinformatic approaches to control Acinetobacter baumannii.
Tabibpour NS, Doosti A, Sharifzadeh A. Tabibpour NS, et al. BMC Immunol. 2023 Nov 18;24(1):46. doi: 10.1186/s12865-023-00585-w. BMC Immunol. 2023. PMID: 37980458 Free PMC article. - Enhancing Immunity and Modulating Vaginal Microflora Against Candidal Vaginitis Through Nanoemulsion Supplemented with Porphyra Oligosaccharide as an Intravaginal Vaccine Adjuvant.
Tsai WC, Liu FL, Huang MH, Huang CH. Tsai WC, et al. Int J Nanomedicine. 2023 Nov 6;18:6333-6346. doi: 10.2147/IJN.S431009. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37954454 Free PMC article. - A new vaccination regimen using adenovirus-vectored vaccine confers effective protection against African swine fever virus in swine.
Liu W, Li H, Liu B, Lv T, Yang C, Chen S, Feng L, Lai L, Duan Z, Chen X, Li P, Guan S, Chen L. Liu W, et al. Emerg Microbes Infect. 2023 Dec;12(2):2233643. doi: 10.1080/22221751.2023.2233643. Emerg Microbes Infect. 2023. PMID: 37401832 Free PMC article. - The Upper Nasal Space: Option for Systemic Drug Delivery, Mucosal Vaccines and "Nose-to-Brain".
Shrewsbury SB. Shrewsbury SB. Pharmaceutics. 2023 Jun 13;15(6):1720. doi: 10.3390/pharmaceutics15061720. Pharmaceutics. 2023. PMID: 37376168 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical